Crowdsourcing to Promote Hepatitis C Testing and Linkage-to-care in China: a Randomized Controlled Trial Protocol

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900025771

Enrollment

Unknown

Registered

2019-09-07

Start date

2019-09-16

Completion date

Unknown

Last updated

2019-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatitis C

Interventions

Group 2:Crowd-sourcing contest materials to increase HCV uptake

Group 1:Standard of care on HCV testing uptake

Eligibility

Sex/Gender

All

Age

30 Years to 100 Years

Inclusion criteria

Inclusion criteria: Participants will be invited to participate if they are 30 years old or older, a Chinese, and will reside in Shenzhen for the following month.

Exclusion criteria

Exclusion criteria: Participants will be excluded if they self-report one of the followings: known chronic HCV infection, testing for serum anti-HCV in the past 12 months, current or planned pregnancy, currently undergoing complex medical treatment for other conditions.

Design outcomes

Primary

Measure	Time frame
Number of HCV antibody screening test uptake;	—

Secondary

Measure	Time frame
Number of participants that additionally self-report HBsAg testing with/without confirmation by medical records or HBsAg viral load confirmatory testing;Rate of participation in the crowdsourcing intervention;Content of feedback submissions;Number of participants that self-report HCV antibody testing but are not confirmed by medical records;Number of participants that enrol in VCT service at HKU-SZH;Number of participants that follow-up for HCV confirmatory testing;Number of participants that join the peer training program at HKU-SZH;Number of HCV diagnosed participants to continue with anti-HCV treatment, versus those who decline treatment for any reason;Number of participants that will be completely cured of HCV infection, versus number that drop out prior to completing treatment;Number of participants diagnosed with chronic liver disease (including cirrhosis, liver failure, or hepatocellular carcinoma);Number of participants that will return to primary care for chronic liver disease follow-up or future screening of HCV and other conditions;	—

Measure

Time frame

Number of participants that additionally self-report HBsAg testing with/without confirmation by medical records or HBsAg viral load confirmatory testing;Rate of participation in the crowdsourcing intervention;Content of feedback submissions;Number of participants that self-report HCV antibody testing but are not confirmed by medical records;Number of participants that enrol in VCT service at HKU-SZH;Number of participants that follow-up for HCV confirmatory testing;Number of participants that join the peer training program at HKU-SZH;Number of HCV diagnosed participants to continue with anti-HCV treatment, versus those who decline treatment for any reason;Number of participants that will be completely cured of HCV infection, versus number that drop out prior to completing treatment;Number of participants diagnosed with chronic liver disease (including cirrhosis, liver failure, or hepatocellular carcinoma);Number of participants that will return to primary care for chronic liver disease follow-up or future screening of HCV and other conditions;

—

Countries

China

Contacts

Public ContactWilliam Chi Wai Wong

University of Hong Kong-Shenzhen Hospital

wongwcw@hku.hk+852 2518 5650

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 26, 2026